-->

Innovative therapeutics

Investors

NASDAQBMRN
FormDescriptionDateFormat
SC 13G/AAmendment to a previously filed SC 13GDec 11, 2012View HTMLDownload DOCDownload PDFDownload XLS
SC 13GSchedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutionsNov 5, 2012View HTMLDownload DOCDownload PDFDownload XLS
CT ORDERConfidential treatment orderSep 14, 2012View HTMLDownload DOCDownload PDF
S-3ASRAutomatic shelf registration statement of securities of well-known seasoned issuersMay 30, 2012View HTMLDownload DOCDownload PDFDownload XLS
UPLOADCorrespondence from the SEC to the FilerMay 15, 2012Download DOCDownload PDF
CORRESPCorrespondence from the Filer to the SECMay 3, 2012View HTMLDownload DOCDownload PDFDownload XLS
UPLOADCorrespondence from the SEC to the FilerApr 27, 2012Download DOCDownload PDF
CORRESPCorrespondence from the Filer to the SECApr 2, 2012View HTMLDownload DOCDownload PDFDownload XLS
UPLOADCorrespondence from the SEC to the FilerMar 23, 2012Download DOCDownload PDF
SC 13G/AAmendment to a previously filed SC 13GMar 12, 2012View HTMLDownload DOCDownload PDF
SC 13G/AAmendment to a previously filed SC 13GFeb 14, 2012View HTMLDownload DOCDownload PDF
SC 13G/AAmendment to a previously filed SC 13GFeb 14, 2012View HTMLDownload DOCDownload PDF
SC 13G/AAmendment to a previously filed SC 13GFeb 13, 2012View HTMLDownload DOCDownload PDF
SC 13G/AAmendment to a previously filed SC 13GFeb 13, 2012View HTMLDownload DOCDownload PDFDownload XLS
SC 13G/AAmendment to a previously filed SC 13GFeb 10, 2012View HTMLDownload DOCDownload PDFDownload XLS
SC 13GSchedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutionsFeb 9, 2012View HTMLDownload DOCDownload PDF

BioMarin

Diseases

Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI, CLN2 disease) PKU, LEMS

Products

Palynziq™
Brineura™
Vimizim®
Kuvan®
Naglazyme®
Aldurazyme®
Firdapse®

Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: support@biomarin-rareconnections.com

Global Medical Information

Contact Global Medical Information